Sort   by:  
 Page size 
2 million E. histolytica HM1:IMSS was treated with 0.5% DMSO for 3 h and 2 million E. histolytica HM1:IMSS was treated with 1 M-5M auranofin for 3 h
ORGANISM(S): Entamoeba histolytica 
Auranofin, an FDA-approved antirheumatic drug, has been reported to have anti-tumoral properties but its immunological effects and significance are not well understood. This study is the first to report auranofin-induced regulatory T cell (Treg) expansion. In a mouse model with B16F10 melanoma, aura...
ORGANISM(S): Mus musculus (Mouse) 
2025-12-08 | PXD060423 | Pride
One of the significant features of cancer cells is a persistent pro-oxidative status. Therefore, compared to their normal counterparts, the malignant cells are generally more dependent on antioxidants for cell survival and more vulnerable to further oxidative insults via pharmacolog-ical interventio...
ORGANISM(S): Homo sapiens (Human) 
2023-03-11 | PXD036558 | Pride
Chemical proteomics encompasses novel drug target deconvolution methods in which compound modification is not required. Herein we use Thermal Proteome Profiling, Functional Identification of Target by Expression Proteomics and multiplexed redox proteomics for deconvolution of auranofin targets to ai...
ORGANISM(S): Homo sapiens (Human) 
2020-03-19 | PXD016776 | Pride
Auranofin, an FDA-approved antirheumatic drug, has been reported to have anti-tumoral properties but its immunological effects and significance are not well understood. This study is the first to report auranofin-induced regulatory T cell (Treg) expansion. In a mouse model with B16F10 melanoma, aura...
ORGANISM(S): Mus musculus (Mouse) 
2025-12-08 | PXD069997 | Pride
UBA1 is the primary E1 ubiquitin-activating enzyme, regulating stability and function of numerous proteins via initiating their ubiquitination. Decreased or insufficient ubiquitination can cause or drive aging and many deadly diseases. Therefore, a small-molecule UBA1 activity enhancer could have br...
ORGANISM(S): Homo sapiens (Human) 
2023-07-10 | PXD042558 | Pride
Candida albicans lab strain SC5314 was grown in YPD broth at 30C°C from OD=66=0.1 till 1.0. The culture was divided into two batches. One batch was treated with 16 μg/mL auranofin. The other batch was treated with the same volume of vehicle (DMSO). After three hours, cells were harvested for RNA-Seq...
ORGANISM(S): Candida albicans 
Auranofin prevents liver fibrosis by system Xc-mediated inhibition of NLRP3 inflammasome
Transcriptome analysis of Candida albicans treated with auranofin
The effects of Auranofin (AF) on protein expression and protein oxidation in A2780 cancer cells were explored through a robust investigative strategy based on joint expression proteomics and redox proteomics determinations. Bioinformatics analysis of the proteomics data supports the view that the mo...
ORGANISM(S): Homo sapiens (Human) 
2022-05-19 | PXD028681 | Pride
Sort   by:  
 Page size